Towards increased selectivity of drug delivery to cancer cells: development of a LDL-based nanodelivery system for hydrophobic photosensitizers

Low-density lipoproteins (LDL), a natural in vivo carrier of cholesterol in the vascular system, play a key role in the delivery of hydrophobic photosensitizers (pts) to tumor cells in photodynamic therapy (PDT) of cancer. To make this delivery system even more efficient, we have constructed a nano-delivery system by coating of LDL surface by polyethylene glycol (PEG) and dextran. Fluorescence spectroscopy and confocal fluorescence imaging were used to characterize redistribution of hypericin (Hyp), a natural potent pts, loaded in LDL/PEG and LDL/dextran complexes to free LDL molecules as well as to monitor cellular uptake of Hyp by U87-MG cells. It was shown than the redistribution process of Hyp between LDL molecules is significantly suppressed by dextran coating of LDL surface. On the other hand, PEG does not significantly influence this process. The modification of LDL molecules by the polymers does not inhibit their recognition by cellular LDL receptors. U-87 MG cellular uptake of Hyp loaded in LDL/PEG and LDL/dextran complexes appears to be similar to that one observed for Hyp transported by unmodified LDL particles. It is proposed that by polymers modified LDL molecules could be used as a basis for construction of a drug transport system for targeted delivery of hydrophobic drugs to cancer cells expressing high level of LDL receptors.

[1]  D. Chorvat,et al.  Kinetics of Hypericin Association With Low‐Density Lipoproteins , 2011, Photochemistry and photobiology.

[2]  Dion R. Brocks,et al.  Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery , 2008, Nature Reviews Drug Discovery.

[3]  E. Reddi,et al.  Role of delivery vehicles for photosensitizers in the photodynamic therapy of tumours. , 1997, Journal of photochemistry and photobiology. B, Biology.

[4]  H. Merkle,et al.  PEGylation as a tool for the biomedical engineering of surface modified microparticles. , 2008, Journal of pharmaceutical sciences.

[5]  R. Prassl,et al.  Molecular structure of low density lipoprotein: current status and future challenges , 2009, European Biophysics Journal.

[6]  O. Larsson,et al.  Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo. , 1992, Cancer research.

[7]  J. Kreuter,et al.  Nanoparticulate systems for brain delivery of drugs. , 2001, Advanced drug delivery reviews.

[8]  Qian Peng,et al.  An outline of the hundred-year history of PDT. , 2003, Anticancer research.

[9]  M. Brown,et al.  Receptor-mediated control of cholesterol metabolism. , 1976, Science.

[10]  R. Gurny,et al.  State of the art in the delivery of photosensitizers for photodynamic therapy. , 2002, Journal of photochemistry and photobiology. B, Biology.

[11]  T. V. van Berkel,et al.  Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. , 2001, Advanced drug delivery reviews.

[12]  Ramkrishna Adhikary,et al.  Accumulation and Interaction of Hypericin in Low‐density Lipoprotein— A Photophysical Study , 2008, Photochemistry and photobiology.

[13]  Thomas J. Dougherty,et al.  Basic principles of photodynamic therapy , 2001 .

[14]  T. Efferth,et al.  Molecular mechanisms underlying St. John's wort drug interactions. , 2008, Current drug metabolism.

[15]  R. Dědic,et al.  Time‐resolved Luminescence and Singlet Oxygen Formation After Illumination of the Hypericin–Low‐density Lipoprotein Complex , 2009, Photochemistry and photobiology.

[16]  M. Ala-Korpela,et al.  Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL. , 2000, Biochimica et biophysica acta.

[17]  P. Miškovský,et al.  Hypericin--a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules. , 2002, Current Drug Targets.

[18]  G. Jori,et al.  Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy. , 1996, Journal of photochemistry and photobiology. B, Biology.

[19]  D. Russell,et al.  Cytosolic delivery of LDL nanoparticle cargo using photochemical internalization , 2011 .

[20]  C Simone Fishburn,et al.  The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics. , 2008, Journal of pharmaceutical sciences.

[21]  M. Réfrégiers,et al.  Fluorescence Spectroscopic Study of Hypericin-photosensitized Oxidation of Low-density Lipoproteins , 2005, Photochemistry and photobiology.

[22]  T. Hasan,et al.  Targeted photodynamic therapy , 2006, Lasers in surgery and medicine.

[23]  T. Kiesslich,et al.  Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. , 2006, Current medicinal chemistry.

[24]  S. Bonneau,et al.  Interaction dynamics of hypericin with low-density lipoproteins and U87-MG cells. , 2010, International journal of pharmaceutics.

[25]  Q. Peng,et al.  Photodynamic Therapy , 1988, Methods in Molecular Biology.

[26]  J. Varshosaz.  Dextran conjugates in drug delivery , 2012, Expert opinion on drug delivery.

[27]  Vladimir P Torchilin,et al.  Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. , 2004, Advanced drug delivery reviews.

[28]  Chee-Youb Won,et al.  PEG-modified biopharmaceuticals. , 2009, Expert opinion on drug delivery.

[29]  L. Polo,et al.  Low-density lipoprotein receptors in the uptake of tumour photosensitizers by human and rat transformed fibroblasts. , 2002, The international journal of biochemistry & cell biology.

[30]  P. Morlière,et al.  Equilibrium and kinetic studies of the interactions of a porphyrin with low-density lipoproteins. , 2002, Biophysical journal.

[31]  Michael R Hamblin,et al.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death. , 2005, Photodiagnosis and photodynamic therapy.

[32]  J. V. van Lier,et al.  Targeted photodynamic therapy via receptor mediated delivery systems. , 2004, Advanced drug delivery reviews.

[33]  Hui Li,et al.  Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Mikes,et al.  High Level of Low‐density Lipoprotein Receptors Enhance Hypericin Uptake by U‐87 MG Cells in the Presence of LDL , 2007, Photochemistry and photobiology.

[35]  P. D. de Witte,et al.  Liposomes for photodynamic therapy. , 2004, Advanced drug delivery reviews.

[36]  B. Pogue,et al.  Liposomal delivery of photosensitising agents , 2005, Expert opinion on drug delivery.